|
2024
|
G/S
|
Pharmaceutical preparations for the treatment of allergies and allergic diseases and disorders, a... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for the t... |
|
|
G/S
|
Pharmaceutical preparations. |
|
|
Invention
|
Binding molecules. The present disclosure provides transgenic non-human animal cells that are use... |
|
|
Invention
|
Dosing and treatment of immune-mediated diseases and biomarkers associated with immune-mediated d... |
|
|
Invention
|
Use of ox40 and ox40l modulators to treat hidradenitis suppurativa. The present disclosure provid... |
|
|
Invention
|
Pharmaceutical formulations containing anti-ox40l antibodies.
The present disclosure provides aq... |
|
|
Invention
|
Pharmaceutical formulations containing anti-ox40l antibodies. The present disclosure provides aqu... |
|
|
Invention
|
Multispecific antibodies for immuno-oncology.
Multispecific antibody having a binding site for I... |
|
|
Invention
|
Anti-pd-l1 and il-2 cytokines.
The present invention relates to anti-PD-L1 antibodies, bispecifi... |
|
|
Invention
|
Antibodies.
The invention relates to antibodies or antigen-binding fragments thereof which speci... |
|
|
Invention
|
Antibodies. The invention relates to antibodies or antigen-binding fragments thereof which specif... |
|
2023
|
Invention
|
Antagonists and agonists of the transferrin receptor-2 for use in the treatment of diseases of th... |
|
|
Invention
|
Use of the extracellular domain of transferrin receptor 2 for the diagnosis and treatment of prim... |
|
|
Invention
|
Methods, cells & organisms.
The invention relates to an approach for introducing one or more des... |
|
|
Invention
|
Treatment of pd-l1 negative or low expressing cancer with anti-icos antibodies.
This invention r... |
|
|
Invention
|
Anti-icos antibodies.
Antibodies that bind ICOS (Inducible T cell Co-Stimulator). Therapeutic us... |
|
|
Invention
|
Antibodies, combinations comprising antibodies, biomarkers, uses & methods.
The present inventio... |
|
|
Invention
|
Antibodies, uses & methods.
The present invention related to anti-human OX40L antibodies, new me... |
|
|
Invention
|
Uses of anti-icos antibodies. Therapeutic use and dosing regimen of anti-ICOS antibodies or antig... |
|
|
Invention
|
Anti-opg antibodies.
The present invention relates to anti-OPG antibodies, and to methods of tre... |
|
|
Invention
|
Bispecific antibody for icos and pd-l1.
Multispecific antibody in mAb2 format, comprising an ICO... |
|
2022
|
Invention
|
Precision medicine for cholesterol treatment.
The invention relates to human targets of interest... |
|
|
Invention
|
Antibodies for use as therapeutics against bacterial infections.
The present invention relates t... |
|
|
Invention
|
Antibodies for use as therapeutics against bacterial infections. Acinetobacter baumanniiAcinetoba... |
|
|
Invention
|
Animal models and therapeutic molecules.
The invention discloses methods for the generation of c... |
|
|
Invention
|
Methods, regimens, combinations & antagonists.
The invention relates to treating or preventing a... |
|
|
Invention
|
Treatment of atopic dermatitis.
The present invention relates to methods of treating Atopic Derm... |
|
|
Invention
|
Treatment of atopic dermatitis. The present invention relates to methods of treating Atopic Derma... |
|
|
Invention
|
Human targets.
The invention relates to human targets of interest (TOI), anti-TOI ligands, kits ... |
|
|
Invention
|
Tigit antibodies, encoding nucleic acids and methods of using said antibodies in vivo.
The prese... |
|
|
Invention
|
Treatment of pd-l1 negative or low expressing cancer with anti-icos antibodies. This invention re... |
|
|
Invention
|
Expression vector production and high-throughput cell screening.
The present invention relates i... |
|
|
Invention
|
Uses of anti-icos antibodies.
Therapeutic use and dosing regimen of anti-ICOS antibodies or anti... |
|
|
Invention
|
Therapeutic inhibitors of gdf15 signalling.
This invention relates to antibodies that bind to an... |
|
2021
|
Invention
|
Antibodies against sars-cov-2 and uses thereof.
The present invention relates to antibodies that... |
|
|
G/S
|
Pharmaceutical preparations for the prevention of diseases and disorders caused by bacteria; phar... |
|
|
G/S
|
Pharmaceuticals, medical and veterinary preparations;
sanitary preparations for medical purposes... |
|
|
G/S
|
Pharmaceuticals, medical and veterinary preparations for the treatment and prevention of immunolo... |
|
|
G/S
|
Pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for t... |
|
|
G/S
|
Pharmaceuticals; pharmaceutical preparations for the
prevention of disorders caused by bacteria;... |
|
|
Invention
|
Methods of treating anaemia.
The invention relates to human targets of interest (TOI), anti-TOI ... |
|
|
Invention
|
Tumour biomarkers for immunotherapy.
Biomarkers for prognosis of tumours, in hepatocellular carc... |
|
2020
|
Invention
|
Expression of sequence-engineered lambda antibody light chains.
Expression of lambda antibody li... |
|
|
Invention
|
Treatment for physiological iron overload.
Antibodies to the enzyme matriptase-2 (MTP-2) are pre... |
|
|
Invention
|
Improved lambda antibodies.
Immunoglobulin lambda variable domain sequence adapted for expressio... |
|
2019
|
G/S
|
Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes;... |
|
|
G/S
|
Pharmaceutical and medical preparations containing monoclonal antibodies for the treatment and pr... |
|
|
G/S
|
Pharmaceuticals; pharmaceutical preparations for the prevention of disorders caused by bacteria; ... |
